Results of a phase II clinical trial to evaluate a re-challenge of intraperitoneal catumaxomab for treatment of malignant ascites (MA) due to epithelial cancer (SECIMAS).

被引：0
|
作者：
Pietzner, Klaus
Vergote, Ignace
Santoro, Armando
Marme, Frederik
Rosenberg, Per
Friccius-Quecke, Hilke
Sehouli, Jalid
机构：
[1] Charite, D-13353 Berlin, Germany
[2] UZ Leuven, Louvain, Belgium
[3] Ist Clin Humanitas, Humanitas Canc Ctr, Rozzano, Italy
[4] Univ Heidelberg Hosp, Dept Obstet & Gynecol, Heidelberg, Germany
[5] NSGO, Linkoping, Sweden
[6] Linkoping Univ Hosp, Onkol Kliniken Univ Sjukhuset, S-58185 Linkoping, Sweden
[7] Fresenius Biotech GmbH, Munich, Germany
[8] Charite Campus Virchow Klinikum, European Competence Ctr Ovarian Canc, Dept Gynecol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5582
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II clinical trial to evaluate the safety of repeated cycles of intraperitoneal catumaxomab for the treatment of malignant ascites (SECIMAS)
    Pietzner, K.
    Linke, R. G.
    Jaeger, M.
    Lindhofer, H.
    Friccius-Quecke, H.
    Chen, F.
    Braicu, E. I.
    Oskay-Oezcelik, G.
    Sehouli, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
    Pietzner, Klaus
    Vergote, Ignace
    Santoro, Armando
    Chekerov, Radoslav
    Marme, Frederik
    Rosenberg, Per
    Martinius, Holger
    Friccius-Quecke, Hilke
    Sehouli, Jalid
    MEDICAL ONCOLOGY, 2014, 31 (12) : 1 - 8
  • [3] Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
    Klaus Pietzner
    Ignace Vergote
    Armando Santoro
    Radoslav Chekerov
    Frederik Marmé
    Per Rosenberg
    Holger Martinius
    Hilke Friccius-Quecke
    Jalid Sehouli
    Medical Oncology, 2014, 31
  • [4] Intraperitoneal treatment of malignant ascites due to epithelial tumors with catumaxomab: A phase II/III study
    Parsons, S.
    Murawa, P. X.
    Koralewski, P.
    Kutarska, E.
    Kolesnik, O. O.
    Stroehlein, M. A.
    Lahr, A.
    Jaeger, M.
    Heiss, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial
    Heiss, Markus M.
    Murawa, Pawel
    Koralewski, Piotr
    Kutarska, Elzbieta
    Kolesnik, Olena O.
    Ivanchenko, Vladimir V.
    Dudnichenko, Alexander S.
    Aleknaviciene, Birute
    Razbadauskas, Arturas
    Gore, Martin
    Ganea-Motan, Elena
    Ciuleanu, Tudor
    Wimberger, Pauline
    Schmittel, Alexander
    Schmalfeldt, Barbara
    Burges, Alexander
    Bokemeyer, Carsten
    Lindhofer, Horst
    Lahr, Angelika
    Parsons, Simon L.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (09) : 2209 - 2221
  • [6] Intraperitoneal administration of the trifunctional antibody catumaxomab for treatment of malignant ascites due to ovarian carcinoma: Results of a phase II/III study
    Parsons, S.
    Kutarska, E.
    Koralewski, P.
    Gore, M.
    Wimberger, R.
    Burges, A.
    Sroehlein, M. A.
    Friccius-Quecke, H.
    Jaeger, M.
    Heiss, M. M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 311 - 311
  • [7] Treatment of malignant ascites with catumaxomab in clinical practice: Results of an observational trial
    Kurbacher, C.
    Sehouli, J.
    Welslau, M.
    von Tempelhoff, G-F
    Kuhfahl, J.
    Marth, C.
    Oettle, H.
    Schmalfeldt, B.
    Schulze, E.
    Kunzmann, V
    ONKOLOGIE, 2013, 36 : 280 - 280
  • [8] Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
    Sehouli, Jalid
    Pietzner, Klaus
    Wimberger, Pauline
    Vergote, Ignace
    Rosenberg, Per
    Schneeweiss, Andreas
    Bokemeyer, Carsten
    Salat, Christoph
    Scambia, Giovanni
    Berton-Rigaud, Dominique
    Santoro, Armando
    Cervantes, Andres
    Tredan, Olivier
    Tournigand, Christophe
    Colombo, Nicoletta
    Dudnichenko, Alexander S.
    Westermann, Anneke
    Friccius-Quecke, Hilke
    Lordick, Florian
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [9] Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study
    Jalid Sehouli
    Klaus Pietzner
    Pauline Wimberger
    Ignace Vergote
    Per Rosenberg
    Andreas Schneeweiss
    Carsten Bokemeyer
    Christoph Salat
    Giovanni Scambia
    Dominique Berton-Rigaud
    Armando Santoro
    Andrés Cervantes
    Olivier Trédan
    Christophe Tournigand
    Nicoletta Colombo
    Alexander S. Dudnichenko
    Anneke Westermann
    Hilke Friccius-Quecke
    Florian Lordick
    Medical Oncology, 2014, 31
  • [10] The use of catumaxomab for treatment of malignant ascites in clinical practice: Results of an observational trial
    Kurbacher, C.
    Sehouli, J.
    Welslau, M.
    Tempelhofr, G. F.
    Kufahl, J.
    Marth, C.
    Oettle, H.
    Schmalfeldt, B.
    Schulze, E.
    Kunzmann, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S288 - S289
12345